HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Sbt-119

a P2Y1 receptor antagonist with antithrombotic activity

Also Known As:

N-((1-morpholinopropylamino)carbonyl-2-(1-ethyl-1H-indole-3-yl)vinyl)-4-methylphenylamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Oxazines: 9
    - Morpholines: 6
      - Sbt-119: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Sbt-119: 1

Experts

1.	Bukatina, T M: 1 article (11/2014)
2.	Smirnov, A V: 1 article (11/2014)
3.	Spasov, A A: 1 article (11/2014)
4.	Suzdalev, K F: 1 article (11/2014)
5.	Yakovlev, D S: 1 article (11/2014)

Related Diseases

1.

Thrombosis (Thrombus)

11/01/2014 - "Antithrombotic activity of a new P2Y1 receptor antagonist, substance Sbt-119, on experimental models of thromboses in rats."
11/01/2014 - "Antithrombotic properties of a new P2Y1 receptor antagonist N-[(1-morpholinopropyl-amino)- carbonyl-2-(1-ethyl-1H-indole-3-yl)-vinyl]-4-methylphenyl-amide hydrochloride, substance Sbt-119, and reference drug ticlopidine were studied on experimental models of arterial and systemic thromboses. "

Related Drugs and Biologics

1.	Purinergic P2Y1 Receptors
2.	Ticlopidine (Ticlid)
3.	Amides
4.	indole